Advertisement

Comprehensive evaluation of irisin levels in fetomaternal circulation of pregnant women with obesity or gestational diabetes mellitus

  • Ali SevenEmail author
  • Esin Yalinbas
  • Suna Kabil Kucur
  • Emel Kocak
  • Ozben Isiklar
  • Beril Yuksel
  • Hakan Timur
  • Mehmet Erbakirci
  • Nadi Keskin
Original Article
  • 16 Downloads

Abstract

Aim

To evaluate maternal and cord blood irisin levels in pregnant women with gestational diabetes mellitus (GDM) and in obese pregnant women without GDM.

Methods

The study included 109 patients, with 34 patients in the GDM group, 40 in the obese non-GDM group, and 35 in the control group. Maternal serum irisin levels at the time of delivery were measured by an enzyme-linked immunosorbent assay kit. The correlation of serum irisin levels with metabolic parameters and anthropometric measurements was analyzed.

Results

There were significant differences between the study groups in terms of cord arterial, cord venous, and maternal serum irisin levels (P < 0.001, P < 0.01, P < 0.001, respectively). Cord arterial, cord venous, and maternal serum irisin levels were higher in the obese group compared to the control (P < 0.01, P < 0.01, P < 0.01, respectively) and the GDM group (P < 0.001, P < 0.001, P < 0.001, respectively).

Conclusion

Elevation in irisin levels of women who have pregnancies complicated with obesity may be explained as part of the compensation mechanism against disturbed metabolic functions. Pregnant individuals with GDM have lower serum irisin levels in comparison to healthy pregnant women. In this regard, it is possible that the measurement of serum irisin levels may be utilized in the future for prediction, prevention, and treatment of GDM.

Keywords

Gestational diabetes mellitus Irisin Obesity Pregnancy 

Notes

Compliance with ethical standards

The study was performed in accordance with the Declaration of Helsinki. Ethical committee approval was received from the local Human Research Ethics Committee (issue number: 2015-KAEK-86/10). Written informed consent was obtained from all volunteers.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Joung KE, Park KH, Filippaios A, Dincer F, Christou H, Mantzoros CS et al (2015) Cord blood irisin levels are positively correlated with birth weight in newborn infants. Metabolism 64:1507–1514CrossRefGoogle Scholar
  2. 2.
    Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Højlund K, Gygi SP, Spiegelman BM (2012) A PGC1- α -dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463–468CrossRefGoogle Scholar
  3. 3.
    Aydin S (2014) Three new players in energy regulation: preptin, adropin and irisin. Peptides 56:94–110CrossRefGoogle Scholar
  4. 4.
    Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W, Fernández-Real JM (2013) Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J ClinEndocrinolMetab 98:E769–E778CrossRefGoogle Scholar
  5. 5.
    Park KH, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE et al (2013) Circulating irisin in relation to insulin resistance and the metabolic syndrome. J ClinEndocrinolMetab 98:4899–4907CrossRefGoogle Scholar
  6. 6.
    Bostrom PA, Fernandez-Real JM, Mantzoros C (2014) Irisinin humans: recent advances and questions for future research. Metabolism 63:178–180CrossRefGoogle Scholar
  7. 7.
    Ebert T, Stepan H, Schrey S, Kralisch S, Hindricks J, Hopf L, Platz M, Lossner U, Jessnitzer B, Drewlo S, Blüher M, Stumvoll M, Fasshauer M (2014) Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery. Cytokine 65:153–158CrossRefGoogle Scholar
  8. 8.
    Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, Ng XW et al (2013) Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complicat 27:365–369CrossRefGoogle Scholar
  9. 9.
    Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, Kim JG, Lee IK, Park KG (2013) Serum irisin levels in new onset type 2 diabetes. Diabetes Res ClinPract 100:96–101CrossRefGoogle Scholar
  10. 10.
    Kuzmicki M, Telejko B, Lipinska D, Pliszka J, Szamatowicz M, Wilk J et al (2014) Serum irisin concentration in women with gestational diabetes. GynecolEndocrinol. 30:636–639Google Scholar
  11. 11.
    Yuksel MA, Oncul M, Tuten A, Imamoglu M, Acikgoz AS, Kucur M, Madazli R (2014) Maternal serum and fetal cord blood irisin levels in gestational diabetes mellitus. Diabetes Res ClinPract 104:171–175CrossRefGoogle Scholar
  12. 12.
    Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF (2013) Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity--correlation with body mass index. Peptides. 39:125–130CrossRefGoogle Scholar
  13. 13.
    Carpenter MW, Coustan DR (1982) Criteria for screening tests for gestational diabetes. Am J ObstetGynecol 144:768–773CrossRefGoogle Scholar
  14. 14.
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefGoogle Scholar
  15. 15.
    Sanchis-Gomar F, Alis R, Pareja-Galeano H et al (2014) Inconsistency in circulating irisin levels: what is really happening? HormMetab Res 46:591–596Google Scholar
  16. 16.
    Zhao L, Li J, Li ZL, Yang J, Li ML, Wang GL (2015) Circulating irisin is lower in gestational diabetes mellitus. Endocr J 62:921–926CrossRefGoogle Scholar
  17. 17.
    Baka S, Malamitsi-Puchner A, Boutsikou T, Boutsikou M, Marmarinos A, Hassiakos D, Gourgiotis D, Briana DD (2015) Cord blood irisin at the extremes of fetal growth. Metabolism. 64:1515–1520CrossRefGoogle Scholar
  18. 18.
    Çağlar M, Göksu M, Isenlik BS, Yavuzcan A, Yılmaz M, Üstün Y, Aydin S, Kumru S (2014) Irisin in idiopathic foetal growth restriction. J Endocrinol Investig 37:619–624CrossRefGoogle Scholar
  19. 19.
    Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS (2012) FNDC5 and irisin in humans: I. predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61:1725–1738CrossRefGoogle Scholar
  20. 20.
    Gutierrez-Repiso C, Garcia-Serrano S, Rodriguez-Pacheco F, Garcia-Escobar E, Haro-Mora JJ, Garcia-Arnes J, Valdes S, Gonzalo M, Soriguer F, Moreno-Ruiz FJ, Rodriguez-Cañete A, Martinez-Ferriz A, Santoyo JS, Perez-Valero V, Garcia-Fuentes E (2014) FNDC5 could be regulated by leptin in adipose tissue. Eur J Clin Investig 44:918–925CrossRefGoogle Scholar
  21. 21.
    Pardo M, Crujeiras AB, Amil M, Aguera Z, Jiménez-Murcia S, Baños R et al (2014) Association of irisin with fat mass, resting energy expenditure and daily activity in conditions of extreme body mass index. Int J Endocrinol 2014:857270CrossRefGoogle Scholar
  22. 22.
    Huerta AE, Prieto-Hontoria PL, Fernández-Galilea M, Sáinz N, Cuervo M, Martínez JA et al (2015) Circulating irisin and glucose metabolism in overweight/obese women: effects of α-lipoic acid and eicosapentaenoic acid. J PhysiolBiochem 71:547–558Google Scholar
  23. 23.
    Aktün HL, Uyan D, Yorgunlar B, Acet M (2015) Gestational diabetes mellitus screening and outcomes. J Turk GerGynecol Assoc 16:25–29CrossRefGoogle Scholar
  24. 24.
    Kennelly MA, McAuliffe FM (2016) Prediction and prevention of gestational diabetes: an update of recent literature. Eur J ObstetGynecolReprodBiol 202:92–98Google Scholar
  25. 25.
    Bao W, Baecker A, Song Y et al (2015) Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: a systematic review. MetabClinExp 64:756–764Google Scholar
  26. 26.
    Erol O, Erkal N, Ellidağ HY, İsenlik BS, Aydın Ö, Derbent AU et al (2016) Irisin as an early marker for predicting gestational diabetes mellitus: a prospective study. J Matern Fetal Neonatal Med 26:1–6Google Scholar
  27. 27.
    Sanchis-Gomar F, Alis R, Pareja-Galeano H, Sola E, Victor VM, Rocha M, Hernández-Mijares A, Romagnoli M (2014) Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients. Endocrine 46:674–677CrossRefGoogle Scholar

Copyright information

© Royal Academy of Medicine in Ireland 2019

Authors and Affiliations

  • Ali Seven
    • 1
    Email author
  • Esin Yalinbas
    • 2
  • Suna Kabil Kucur
    • 1
  • Emel Kocak
    • 3
  • Ozben Isiklar
    • 4
  • Beril Yuksel
    • 1
  • Hakan Timur
    • 5
  • Mehmet Erbakirci
    • 1
  • Nadi Keskin
    • 1
  1. 1.Department of Obstetrics and Gynecology KutahyaDumlupinar University School of MedicineKütahyaTurkey
  2. 2.Department of Pediatrics KutahyaDumlupinar University School of MedicineKütahyaTurkey
  3. 3.Department of Biochemistry KutahyaDumlupinar University School of MedicineKütahyaTurkey
  4. 4.Department of Biochemistry KutahyaDumlupinar University Kutahya Evliya Celebi Training and Research HospitalKütahyaTurkey
  5. 5.Department of Obstetrics and Gynecology AnkaraZekai Tahir Burak Women’s Health Training and Research HospitalKütahyaTurkey

Personalised recommendations